日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Co-occurrence of clonally related follicular lymphoma and histiocytic sarcoma

克隆相关的滤泡性淋巴瘤和组织细胞肉瘤的共存

Haebe, Sarah; Czerwinski, Debra K; Sathe, Anuja; Grimes, Susan M; Chen, Tianqi; Suarez, Carlos J; Martin, Brock; Ji, Hanlee P; Levy, Ronald; Shree, Tanaya

A Phase I Clinical Trial Adding OX40 Agonism to In Situ Therapeutic Cancer Vaccination in Patients with Low-Grade B-cell Lymphoma Highlights Challenges in Translation from Mouse to Human Studies.

一项针对低级别 B 细胞淋巴瘤患者的 I 期临床试验,将 OX40 激动剂添加到原位治疗性癌症疫苗中,凸显了从小鼠研究到人体研究转化过程中面临的挑战

Shree Tanaya, Czerwinski Debra, Haebe Sarah, Sathe Anuja, Grimes Sue, Martin Brock, Ozawa Michael, Hoppe Richard, Ji Hanlee, Levy Ronald

A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis

一项针对淋巴瘤的治疗性疫苗临床试验,采用连续肿瘤取样和单细胞分析方法。

Shree, Tanaya; Haebe, Sarah; Czerwinski, Debra K; Eckhert, Erik; Day, Grady; Sathe, Anuja; Grimes, Susan; Frank, Matthew J; Maeda, Lauren S; Alizadeh, Ash A; Advani, Ranjana; Hoppe, Richard T; Long, Steven R; Martin, Brock; Ozawa, Michael G; Khodadoust, Michael S; Ji, Hanlee P; Levy, Ronald

Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B-cell receptor

滤泡性淋巴瘤的发生发展依赖于B细胞受体中获得的糖基化基序,但这种依赖性是可以克服的。

Haebe, Sarah; Day, Grady; Czerwinski, Debra K; Sathe, Anuja; Grimes, Susan M; Chen, Tianqi; Long, Steven R; Martin, Brock; Ozawa, Michael G; Ji, Hanlee P; Shree, Tanaya; Levy, Ronald

Can B cell-deficient patients rely on COVID-19 vaccine-induced T-cell immunity?

B细胞缺陷患者能否依靠新冠疫苗诱导的T细胞免疫?

Shree, Tanaya

Serial FNA allows direct sampling of malignant and infiltrating immune cells in patients with B-cell lymphoma receiving immunotherapy

连续细针穿刺活检可直接采集接受免疫治疗的B细胞淋巴瘤患者的恶性细胞和浸润性免疫细胞样本。

Mooney, Kelly L; Czerwinski, Debra K; Shree, Tanaya; Frank, Matthew J; Haebe, Sarah; Martin, Brock A; Testa, Stefano; Levy, Ronald; Long, Steven R

Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma

弥漫性大B细胞淋巴瘤幸存者免疫健康受损

Shree, Tanaya; Li, Qian; Glaser, Sally L; Brunson, Ann; Maecker, Holden T; Haile, Robert W; Levy, Ronald; Keegan, Theresa H M

Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model

可逆性组织蛋白酶抑制剂的鉴定和临床前试验表明,其在胰腺癌模型中具有抗肿瘤疗效。

Elie, Benelita Tina; Gocheva, Vasilena; Shree, Tanaya; Dalrymple, Stacie A; Holsinger, Leslie J; Joyce, Johanna A

Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

在1-甲基-4-苯基-1,2,3,6-四氢吡啶帕金森病模型中,Fas对多巴胺能丢失的调节作用

Hayley, Shawn; Crocker, Stephen J; Smith, Patrice D; Shree, Tanaya; Jackson-Lewis, Vernice; Przedborski, Serge; Mount, Matthew; Slack, Ruth; Anisman, Hymie; Park, David S